25 LLC’s Oragenics OGEN Stock Holding History

25 LLC’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.4K	Hold	23,160	–	–	﹤0.01%	76
2026 Q2	$13.4K	Buy	+23,160	New	+$14.1K	﹤0.01%	80

Other funds holding OGEN

HUB Investment Partners Austin, Texas $5.8B AUM 24.38% 1-Year Est. Return

St. Johns Investment Management Jacksonville, Florida $263M AUM 21.67% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

ASCM

Adkins Seale Capital Management Shreveport, Louisiana $121M AUM 21.65% 1-Year Est. Return

25 LLC's OGEN Position: Q3 2026 in Review

25 LLC held its Oragenics (OGEN) position steady in Q3 2026 at 23,160 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #76.

25 LLC first reported a position in OGEN in Q2 2026 and has held it in 2 quarters since. The position peaked at $13.4K in Q2 2026. 6 funds tracked by Wall St. Rank hold OGEN as of Q3 2026.

25 LLC held 23,160 shares of Oragenics worth $11.4K as of Q3 2026.
25 LLC left its Oragenics share count unchanged in Q3 2026.
Oragenics made up ﹤0.01% of 25 LLC's portfolio in Q3 2026, its #76 holding.
25 LLC first reported a position in Oragenics in Q2 2026 and has held it in 2 quarters since.
25 LLC's Oragenics position peaked at $13.4K in Q2 2026.
6 funds tracked by Wall St. Rank held Oragenics as of Q3 2026.

Based on 25 LLC's 13F filing for Q3 2026, filed 13 Oct 2026.